Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-30

Clinical Trial Update: EMERALD: Endocrine Therapy oMission With Radiation in ER+ Breast Cancer: Assessing Quality of Life and Disease Control: a Prospective Phase II Trial [Phase 2]

View source ↗

Summary

A Phase II clinical trial (EMERALD) is evaluating endocrine therapy with radiation for ER-positive breast cancer to assess quality of life and disease control; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING